Akero Therapeutics Inc
Officers & Directors
1. Andrew Cheng - Chief Executive Officer, President, and Director (Principal Executive Officer)
Andrew Cheng, M.D., Ph.D., has over 20 years of experience in the biotechnology and pharmaceutical industries, including leadership positions at several prominent companies. He has a medical degree from Harvard Medical School.
2. William White - Executive Vice President, Chief Financial Officer, and Head of Corporate Development (Principal Financial and Accounting Officer)
William White has extensive experience in finance and corporate development within the biotechnology and pharmaceutical sectors.
3. Judy Chou - Director
Judy Chou brings a wealth of experience to the board with her background in the biotechnology industry.
4. Graham Walmsley - Director
Graham Walmsley has significant expertise in the biotechnology sector and contributes valuable insights to the board.
5. Tom Heyman - Director
Tom Heyman is experienced in the biotechnology field and serves as a useful advisor on the board.
6. Seth L. Harrison - Director
Seth L. Harrison has a strong background in biotechnology and assists in guiding the company’s strategic vision as a director.
7. Yuan Xu - Director
Yuan Xu possesses significant knowledge and experience in the biotech industry, contributing to the board s effectiveness.
8. Jane P. Henderson - Director
Jane P. Henderson offers her extensive experience in biotechnology to the board.
9. Mark Iwicki - Director
Mark Iwicki has a breadth of experience in the biotechnology arena, aiding in the company s leadership.
(Note: Information about Kitty Yale and David Cohen has been omitted as they are no longer listed in the updated information provided.),
Akero Therapeutics Inc currently has 56 employees.
|
